Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (vol 29, pg 2825, 2023)

被引：1

作者：

Galsky, Matthew D. ^{[1
,2
]}

Daneshmand, Siamak ^{[3
]}

Izadmehr, Sudeh ^{[1
]}

Gonzalez-Kozlova, Edgar ^{[4
]}

Chan, Kevin G. ^{[5
]}

Lewis, Sara ^{[6
]}

El Achkar, Bassam ^{[6
]}

Dorff, Tanya B. ^{[7
]}

Cetnar, Jeremy Paul ^{[8
]}

Neil, Brock O. ^{[9
]}

D'Souza, Anishka ^{[10
]}

Mamtani, Ronac ^{[11
]}

Kyriakopoulos, Christos ^{[12
]}

Jun, Tomi ^{[13
,25
]}

Gogerly-Moragoda, Mahalya ^{[1
]}

Brody, Rachel ^{[2
,14
]}

Xie, Hui ^{[15
]}

Nie, Kai ^{[15
]}

Kelly, Geoffrey ^{[15
]}

Horowitz, Amir ^{[2
,16
]}

Kinoshita, Yayoi ^{[14
]}

Ellis, Ethan ^{[17
,18
]}

Nose, Yohei ^{[16
]}

Ioannou, Giorgio ^{[16
]}

Cabal, Rafael ^{[16
]}

Del Valle, Diane M. ^{[16
]}

Haines, G. Kenneth ^{[19
]}

Wang, Li ^{[1
,20
]}

Mouw, Kent W. ^{[21
]}

Samstein, Robert M. ^{[22
]}

Mehrazin, Reza ^{[23
]}

Bhardwaj, Nina ^{[2
,15
,16
]}

Yu, Menggang ^{[24
]}

Zhao, Qianqian ^{[24
]}

Kim-Schulze, Seunghee ^{[2
,15
,16
]}

Sebra, Robert ^{[2
,17
,18
]}

Zhu, Jun ^{[1
,20
]}

Gnjatic, Sacha ^{[2
,15
,16
]}

Sfakianos, John ^{[23
]}

Pal, Sumanta K. ^{[7
]}

机构：

[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[3] Keck Sch Med USC, Dept Urol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[4] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA

[5] City Hope Comprehens Canc Ctr, Dept Urol, Duarte, CA USA

[6] Icahn Sch Med Mt Sinai, Dept Radiol, Tisch Canc Inst, New York, NY 10029 USA

[7] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA

[8] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA

[9] Univ Utah, Dept Urol, Salt Lake City, UT USA

[10] Keck Sch Med USC, Div Hematol & Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[11] Univ Penn, Abramson Canc Ctr, Div Hematol & Med Oncol, Philadelphia, PA 19104 USA

[12] Univ Wisconsin, Div Hematol & Med Oncol, Carbone Canc Ctr, Madison, WI USA

[13] Genentech Inc, San Francisco, CA USA

[14] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA

[15] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA

[16] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA

[17] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[18] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA

[19] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based, New York, NY 10029 USA

[20] Gene Dx, Stamford, CT USA

[21] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA

[22] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, Tisch Canc Inst, New York, NY 10029 USA

[23] Icahn Sch Med Mt Sinai, Dept Urol, Tisch Canc Inst, New York, NY 10029 USA

[24] Univ Wisconsin, Carbone Canc Ctr, Dept Biostat & Med Informat, Madison, WI USA

[25] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

NATURE MEDICINE | 2024年 / 30卷 / 04期

关键词：

D O I：

10.1038/s41591-024-02814-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1211 / 1211

页数：1

共 50 条

[1] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D. Galsky
Siamak Daneshmand
Sudeh Izadmehr
Edgar Gonzalez-Kozlova
Kevin G. Chan
Sara Lewis
Bassam El Achkar
Tanya B. Dorff
Jeremy Paul Cetnar
Brock O. Neil
Anishka D’Souza
Ronac Mamtani
Christos Kyriakopoulos
Tomi Jun
Mahalya Gogerly-Moragoda
Rachel Brody
Hui Xie
Kai Nie
Geoffrey Kelly
Amir Horowitz
Yayoi Kinoshita
Ethan Ellis
Yohei Nose
Giorgio Ioannou
Rafael Cabal
Diane M. Del Valle
G. Kenneth Haines
Li Wang
Kent W. Mouw
Robert M. Samstein
Reza Mehrazin
Nina Bhardwaj
Menggang Yu
Qianqian Zhao
Seunghee Kim-Schulze
Robert Sebra
Jun Zhu
Sacha Gnjatic
John Sfakianos
Sumanta K. Pal
Nature Medicine, 2023, 29 : 2825 - 2834
[2] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Galsky, Matthew D.
Daneshmand, Siamak
Izadmehr, Sudeh
Gonzalez-Kozlova, Edgar
Chan, Kevin G.
Lewis, Sara
Achkar, Bassam El
Dorff, Tanya B.
Cetnar, Jeremy Paul
Neil, Brock O.
D'Souza, Anishka
Mamtani, Ronac
Kyriakopoulos, Christos
Jun, Tomi
Gogerly-Moragoda, Mahalya
Brody, Rachel
Xie, Hui
Nie, Kai
Kelly, Geoffrey
Horwitz, Amir
Kinoshita, Yayoi
Ellis, Ethan
Nose, Yohei
Ioannou, Giorgio
Cabal, Rafael
Haines, G. Kenneth
Wang, Li
Mouw, Kent W.
Samstein, Robert M.
Mehrazin, Reza
Bhardwaj, Nina
Yu, Menggang
Zhao, Qianqian
Kim-Schulze, Seunghee
Sebra, Robert
Zhu, Jun
Gnjatic, Sacha
Sfakianos, John
Pal, Sumanta K.
NATURE MEDICINE, 2023, 29 (11) : 2825 - +
[3] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Moschini, Marco
Necchi, Andrea
Montorsi, Francesco
EUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501
[4] Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D. Galsky
Siamak Daneshmand
Sudeh Izadmehr
Edgar Gonzalez-Kozlova
Kevin G. Chan
Sara Lewis
Bassam El Achkar
Tanya B. Dorff
Jeremy Paul Cetnar
Brock O. Neil
Anishka D’Souza
Ronac Mamtani
Christos Kyriakopoulos
Tomi Jun
Mahalya Gogerly-Moragoda
Rachel Brody
Hui Xie
Kai Nie
Geoffrey Kelly
Amir Horowitz
Yayoi Kinoshita
Ethan Ellis
Yohei Nose
Giorgio Ioannou
Rafael Cabal
Diane M. Del Valle
G. Kenneth Haines
Li Wang
Kent W. Mouw
Robert M. Samstein
Reza Mehrazin
Nina Bhardwaj
Menggang Yu
Qianqian Zhao
Seunghee Kim-Schulze
Robert Sebra
Jun Zhu
Sacha Gnjatic
John Sfakianos
Sumanta K. Pal
Nature Medicine, 2024, 30 : 1211 - 1211
[5] Organ-sparing treatment in muscle-invasive bladder cancer
Dunst, J
Diestelhorst, A
Kühn, R
Müller, AC
Scholz, HJ
Fornara, P
STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (10) : 632 - 637
[6] Organ-sparing precision treatment for muscle-invasive bladder cancer
Li, Roger
NATURE MEDICINE, 2023, 29 (11) : 2709 - 2710
[7] Organ-sparing precision treatment for muscle-invasive bladder cancer
Roger Li
Nature Medicine, 2023, 29 : 2709 - 2710
[8] Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
Witjes, J. Alfred
Feikema, Astrid A. H.
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7833 - 7839
[9] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
Kaneko, Gou
Kikuchi, Eiji
Matsumoto, Kazuhiro
Obata, Jun
Nakamura, So
Miyajima, Akira
Oya, Mototsugu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
[10] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Kim, Hongsik
Jeong, Byong Chang
Hong, Joohyun
Kwon, Ghee Young
Kim, Chan Kyo
Park, Won
Pyo, Hongryull
Song, Wan
Sung, Hyun Hwan
Hong, Jung Yong
Park, Se Hoon
CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642

← 1 2 3 4 5 →